NOTICE: Labnodes will be unavailable on Sunday March 4th for scheduled maintenance from 6-11AM central time.
  1. Human PCSK9 promotes hepatic lipogenesis and atherosclerosis development via apoE- and LDLR-mediated mechanisms. Tavori H, Giunzioni I, Predazzi IM, Plubell D, Shivinsky A, Miles J, Devay RM, Liang H, Rashid S, Linton MF, Fazio S (2016) Cardiovasc Res 110(2): 268-78
    › Citation · 26980204 (PubMed) · PMC4836631 (PubMed Central)
  2. Generation and Characterization of Mice Expressing a Conditional Allele of the Interleukin-1 Receptor Type 1. Robson MJ, Zhu CB, Quinlan MA, Botschner DA, Baganz NL, Lindler KM, Thome JG, Hewlett WA, Blakely RD (2016) PLoS One 11(3): e0150068
    › Citation · 26930558 (PubMed) · PMC4773179 (PubMed Central)
  3. Epithelial NF-κB signaling promotes EGFR-driven lung carcinogenesis via macrophage recruitment. Saxon JA, Sherrill TP, Polosukhin VV, Sai J, Zaynagetdinov R, McLoed AG, Gulleman PM, Barham W, Cheng DS, Hunt RP, Gleaves LA, Richmond A, Young LR, Yull FE, Blackwell TS (2016) Oncoimmunology 5(6): e1168549
    › Citation · 27471643 (PubMed) · PMC4938365 (PubMed Central)
  4. Epithelial-Derived Inflammation Disrupts Elastin Assembly and Alters Saccular Stage Lung Development. Benjamin JT, van der Meer R, Im AM, Plosa EJ, Zaynagetdinov R, Burman A, Havrilla ME, Gleaves LA, Polosukhin VV, Deutsch GH, Yanagisawa H, Davidson JM, Prince LS, Young LR, Blackwell TS (2016) Am J Pathol 186(7): 1786-800
    › Citation · 27181406 (PubMed) · PMC4929391 (PubMed Central)
  5. Differential impact of genetically modulated choline transporter expression on the release of endogenous versus newly synthesized acetylcholine. Iwamoto H, Calcutt MW, Blakely RD (2016) Neurochem Int : 138-45
    › Citation · 27013347 (PubMed) · PMC4969175 (PubMed Central)
  6. Diabetes Caused by Elastase-Cre-Mediated Pdx1 Inactivation in Mice. Kodama S, Nakano Y, Hirata K, Furuyama K, Horiguchi M, Kuhara T, Masui T, Kawaguchi M, Gannon M, Wright CV, Uemoto S, Kawaguchi Y (2016) Sci Rep : 21211
    › Citation · 26887806 (PubMed) · PMC4758062 (PubMed Central)
  7. Contrasting Nav1.8 Activity in Scn10a-/- Ventricular Myocytes and the Intact Heart. Stroud DM, Yang T, Bersell K, Kryshtal DO, Nagao S, Shaffer C, Short L, Hall L, Atack TC, Zhang W, Knollmann BC, Baudenbacher F, Roden DM (2016) J Am Heart Assoc 5(11)
    › Citation · 27806966 (PubMed) · PMC5210363 (PubMed Central)
  8. Class-switched anti-insulin antibodies originate from unconventional antigen presentation in multiple lymphoid sites. Wan X, Thomas JW, Unanue ER (2016) J Exp Med 213(6): 967-78
    › Citation · 27139492 (PubMed) · PMC4886365 (PubMed Central)
  9. Cacna1g is a genetic modifier of epilepsy caused by mutation of voltage-gated sodium channel Scn2a. Calhoun JD, Hawkins NA, Zachwieja NJ, Kearney JA (2016) Epilepsia 57(6): e103-7
    › Citation · 27112236 (PubMed) · PMC4985168 (PubMed Central)
  10. BMP Antagonist Gremlin 2 Limits Inflammation After Myocardial Infarction. Sanders LN, Schoenhard JA, Saleh MA, Mukherjee A, Ryzhov S, McMaster WG, Nolan K, Gumina RJ, Thompson TB, Magnuson MA, Harrison DG, Hatzopoulos AK (2016) Circ Res 119(3): 434-49
    › Citation · 27283840 (PubMed) · PMC4961528 (PubMed Central)